2007 – Woodside, California and Fort Lauderdale, Florida
Myrtle Potter is the founder and CEO of Myrtle Potter and Company, LLC. Myrtle Potter and Company advises public and privately held corporations, senior corporate leaders and boards of directors. Ms. Potter is a member of the Board of Directors of Amazon.com, EV3 and Eleuthera Properties, Ltd. She also serves on the Stanford Graduate School of Business Advisory Council. Prior to founding Myrtle Potter and Company, Ms. Potter’s career spanned close to 30 years in Fortune 500 healthcare corporations. Potter was President of Commercial Operations at Genentech, Inc. where she helped steer the Company through one of the most successful periods in its history. Under her leadership, Genentech’s product revenue stream grew more than three-fold, resulting in record sales and earnings growth for the Company during each of the five years she led the company. Prior to Genentech, Potter was President of Bristol-Myers Squibb’s $4 billion, U.S. Cardiovascular/Metabolics pharmaceutical business. Prior to Bristol-Myers Squibb, Potter worked at Merck where she was Vice President of an $800 million, U.S. business unit. Ms. Potter has been featured on The NBC Today Show, CNBC and Bloomberg Television and Radio. In 2007 she was featured in BusinessWeek as a leading, woman entrepreneur. In 2005 and 2004 she was featured in The Wall Street Journal which listed her as one of its “50 Women To Watch.” In 2003 and 2004 she was listed in FORTUNE magazine’s “Top 50 Most Powerful Women In Business” list. In 2005 she was profiled in Harvard Business Review in an article titled “What Great Leaders Do” and recognized by Black Enterprise magazine as one of the “75 Most Powerful Blacks in Corporate America.” In 2002 Potter created The Myrtle Potter Fund to consolidate the many aspects of her philanthropic work aimed at advancing the status of women and children. Part of this work includes operating a small, privately held real estate development company focused on the housing needs of women and children.